Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Expressions of ZNF436, β-catenin, EGFR, and CMTM5 in breast cancer and their clinical significances

Zhi Chen, Na Cui, Ji-sen Zhao, Jian-fei Wu, Fang Ma, Cong Li, Xian-yi Liu

20-01-2021

https://doi.org/10.4081/ejh.2021.3173

2551

PDF: 910

Supplementary: 238

HTML: 43
Muscleblind-like1 undergoes ectopic relocation in the nuclei of skeletal muscles in myotonic dystrophy and sarcopenia

M. Malatesta, M. Giagnacovo, M. Costanzo, B. Cisterna, R. Cardani, G. Meola

e15

22-04-2013

https://doi.org/10.4081/ejh.2013.e15

3063

PDF: 4416

HTML: 491
Structural and functional alterations of the cell nucleus in skeletal muscle wasting: the evidence in situ

M. Malatesta, G. Meola

e44

19-10-2010

https://doi.org/10.4081/ejh.2010.e44

1658

PDF: 696

HTML: 682
Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction

L.V. Renna, R. Cardani, A. Botta, G. Rossi, B. Fossati, E. Costa, G. Meola

22-10-2014

https://doi.org/10.4081/ejh.2014.2444

2586

PDF: 1213

HTML: 535
Long non-coding RNA WAC antisense RNA 1 mediates hepatitis B virus replication in vitro by reinforcing miR-192-5p/ATG7-induced autophagy

Minkai Cao, Deping Yuan, Hongxiu Jiang, Guanlun Zhou, Chao Chen, Guorong Han

02-09-2022

https://doi.org/10.4081/ejh.2022.3438

1690

PDF: 1040

HTML: 70
Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy

R Cardani, E Mancinelli, V Sansone, G Rotondo, G Meola

437-442

29-06-2009

https://doi.org/10.4081/918

1199

PDF: 892
Skeletal muscle features in myotonic dystrophy and sarcopenia: do similar nuclear mechanisms lead to skeletal muscle wasting?

M. Malatesta

e36

10-08-2012

https://doi.org/10.4081/ejh.2012.e36

1907

PDF: 1039
Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance

Xin Kong, Qi Wang, Jie Li, Ming Li, Fusheng Deng, Chuanying Li

07-04-2022

https://doi.org/10.4081/ejh.2022.3315

1922

PDF: 901

Supplementary: 200

HTML: 32
Super-resolution study of PIAS SUMO E3-ligases in hippocampal and cortical neurons

Andrea Conz, Clara Alice Musi, Luca Russo, Tiziana Borsello, Luca Colnaghi

11-08-2021

https://doi.org/10.4081/ejh.2021.3241

1836

PDF: 827

HTML: 34
Routinely frozen biopsies of human skeletal muscle are suitable for morphological and immunocytochemical analyses at transmission electron microscopy

M. Giagnacovo, R. Cardani, G. Meola, C. Pellicciari, M. Malatesta

e31

08-07-2010

https://doi.org/10.4081/ejh.2010.e31

1699

PDF: 854

HTML: 9430
Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma

Lulu Le, Ji Luo, Haifang Wu, Ling Chen, Xiaoli Tang, Fen Fu

30-03-2021

https://doi.org/10.4081/ejh.2021.3226

2306

PDF: 979

Supplementary: 229

HTML: 47
RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study

F. Perdoni, M. Malatesta, R. Cardani, M. Giagnacovo, E. Mancinelli, G. Meola, C. Pellicciari

e18

23-09-2009

https://doi.org/10.4081/ejh.2009.e18

1829

PDF: 1022
Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies

R Cardani, E Mancinelli, M Giagnacovo, V Sansone, G Meola

e13

17-08-2009

https://doi.org/10.4081/ejh.2009.e13

1210

PDF: 816
High WTAP expression level as a promising biomarker for poor prognosis in colorectal cancer: a pilot study

Michela Relucenti, Claudia Tito, Paolo Mercantini, Emanuela Pilozzi, Claudio Barbaranelli, Loredana Cristiano, Daniela Savarese, Daniela Bastianelli, Francesco Fazi, Vincenzo Petrozza, Xiaobo Li, Rui Chen, Selenia Miglietta, Giuseppe Familiari

16-12-2024

https://doi.org/10.4081/ejh.2024.4145

1634

PDF: 676

HTML: 32
IDMC-6 - The Sixth International Myotonic Dystrophy Consortium Meeting

G Meola

311-313

10-08-2009

https://doi.org/10.4081/1157

702

PDF: 654

1 - 15 of 15 items

Search

Search Results

Expressions of ZNF436, β-catenin, EGFR, and CMTM5 in breast cancer and their clinical significances

Muscleblind-like1 undergoes ectopic relocation in the nuclei of skeletal muscles in myotonic dystrophy and sarcopenia

Structural and functional alterations of the cell nucleus in skeletal muscle wasting: the evidence in situ

Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction

Long non-coding RNA WAC antisense RNA 1 mediates hepatitis B virus replication in vitro by reinforcing miR-192-5p/ATG7-induced autophagy

Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy

Skeletal muscle features in myotonic dystrophy and sarcopenia: do similar nuclear mechanisms lead to skeletal muscle wasting?

Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance

Super-resolution study of PIAS SUMO E3-ligases in hippocampal and cortical neurons

Routinely frozen biopsies of human skeletal muscle are suitable for morphological and immunocytochemical analyses at transmission electron microscopy

Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma

RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study

Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies

High WTAP expression level as a promising biomarker for poor prognosis in colorectal cancer: a pilot study

IDMC-6 - The Sixth International Myotonic Dystrophy Consortium Meeting

authors

reviewers

Categories

If and WoS

indexing

Keywords